Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.69

+0.02 (0.03%)

as of Jul 23, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

PAST TOP PICK

(A Top Pick Jan 04/18, Down 20%) Weathered a perfect storm in 2018 including a short seller. Will discuss this in his Top Picks.

TOP PICK

Broader sector rotation into dividend stocks will benefit financials and lifecos. MFC has had a nice bounce off $18 and should perform well this year. He epxects an interest rate increase that will benefit MFC (he doesn't see an inverted yield curve this year). The short-seller allegations against them were really tenuous and should be resolved soon. MFC is trading at book value and pays a nearly 5% dividend. (Analysts’ price target is $28.25)

PAST TOP PICK

(A Top Pick Jan 23/18, Down 20%) A disappointment, but so have all the insurers. Trading at a "buy" valuation. Would buy for new clients. Manulife is exposed to Asian economy, which is slowing, so there may be an opportunity to buy when the fourth quarter reports. Extremely well capitalized. May see disposal of assets. Lots of strength going forward.

BUY

He has a target price of $31 on it. It is frustrating. There are fears for their business with China; fears of higher interest rates; fears of MFC-T changing it policy. When you build a fortress balance sheet your growth comes down. Eventually the market will catch on to its strong points. 5% yield vs. 4.4% on SLF-T as it has a higher perceived risk, being stuck in Canada.

DON'T BUY

At the bottom of his list. Insurers are hard to analyze. Only ones they ever own are Berkshire Hathaway and Markel. Leaves this to smarter investors. Management has done a great job trying to diversify.

BUY ON WEAKNESS

He thinks it is superb value. His models shows 200% upside potential. Has a nice dividend yield well covered. Despite all this the stock is falling giving him a short term sell technically reaching $16. He likes the stock fundamentally but technically not. All insurance companies look like this.

PAST TOP PICK

(A Top Pick Nov 02/17, Down 27%) All insurers have pulled back because interest rates won't rise as much as expected. Down to 9x earnings with a 5% yield. Valuations are now stunningly low. MFC has Asian operations, but the stock isn't down because of that. It won't stay down at this price.

WEAK BUY

He bought a couple of weeks ago. 8 times core operating earnings. The balance sheet is in better shape. They fixed a lot of their problems and you still have growth in Asia. There is still financial market risk.

DON'T BUY

He thinks financials are facing challenged with rising interest rates. There has been a recent bearish technical analysis, making him overall cautious on the stock. He would not be a buyer at this time.

WEAK BUY

The lifecos in Canada have not done well this year. We saw a breakdown in this one this month. We see rising rates and this should help MFC-T. We have seen a substantial pull down in MFC-T and it tends to do well until April each year.

COMMENT

General opinion of the sector The insurance group had run up earlier in the year as longer term interest rates were expected to rise. However, as short term rates have risen faster this has taken the wind out of the sails. There is still more upside in rates and with yields of 5%, it is a good long term holding. The MFC-T lawsuit over long term contracts will create uncertainty.

PAST TOP PICK

(A Top Pick Sep 26/18, Down 20%) Bought it as an oversold candidate. It's broken down like other stocks. "Old support becomes new resistance," so when stock returns, people start selling.

BUY

Increased their dividend by 20% this year, now above 5%. Interest rates went up--then down, which hurt the lifecos, MFC is doing a good job of selling their legacy businesses, which improves their outlook. Their traditional cash flow out of their Canadian business creates cash flow, and their Asian operation is good especially for long-term.

BUY

The lifecos are attractive after this correction. Solid businesses. SLF has a big U.S. asset management operation. But she prefers (and owns) MFC which has a better valuation. In the past. SLF's earnings have outgrown MFC's, but MFC's should outpace SLF's going forward. MFC trades at a discount to SLF.

BUY

It has probably been hit the hardest because of legacy issues, mostly that have been addressed now.

Showing 436 to 450 of 2,283 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)